hit
counter

Press Releases

Citius Pharmaceuticals Successfully Raises $10 Million

Aug 15, 2018

Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market

Aug 13, 2018

Citius Announces Pricing of $10.0 Million Underwritten Offering Priced At-the-Market

Aug 9, 2018

Citius Announces The Notice Of Allowance From The USPTO On The Advanced Stability Patent Application For Mino-Lok®

Jul 24, 2018

Citius Announces Key Addition to its Scientific Advisory Board

Jul 13, 2018

Citius Provides Clinical Update And Progress Of The Mino-Lok® Phase 3 Trial

Jul 9, 2018

Citius Announces United States Patent & Trademark Office Registered the Company's Mino-Lok® Trademark

Jun 19, 2018

Citius Announces $2.0 Million Registered Direct Offering Priced At-the-Market

Mar 29, 2018

Citius Reports Progress in Hemorroid Treatment Program

Mar 6, 2018

Citius Announces Enrollment Of First Patient In The Mino-Lok™ Phase 3 Trial

Feb 15, 2018

© 2019 Citius Pharmaceuticals | Disclaimer & Terms of Use